Bulletin
Investor Alert

NeuBase Therapeutics Inc.

NAS: NBSE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 26, 2021, 1:31 p.m.

/zigman2/quotes/206101919/composite

$

3.10

Change

0.00 0.00%

Volume

Volume 56

Quotes are delayed by 20 min

/zigman2/quotes/206101919/composite

Previous close

$ 3.26

$ 3.10

Change

-0.16 -4.91%

Day low

Day high

$3.08

$3.24

Open

52 week low

52 week high

$3.03

$12.89

Open

Dietrich A. Stephan

Founder of 6 different companies, including: NeuBase Therapeutics, Inc., Lifecode, Inc. and LifeX Holdings LLC, Dietrich A. Stephan is an entrepreneur and businessperson who has been at the head of 6 different companies and is Chairman for Peptilogics, Inc., Chairman, President, CEO & Chief Financial Officer at NeuBase Therapeutics, Inc. (which he founded in 2018), Director & Chief Scientific Officer at Life Technologies Clinical Services Lab, Inc. (which he founded in 2006) and Chairman-Neuroscience Microarray Consortium at National Institutes of Health. He is also on the board of Sharp Edge Labs, Inc., FarmaceuticalRX LLC, FRX Growth Partners LLC and Epistemix and Member of National Institute of Health Policy and Partner at Cyto Ventures.

In the past he was Chairman at DiaVacs, Inc. (he founded the company), Chief Executive Officer of LifeX Holdings LLC (he founded the company), President & Chief Executive Officer at Neubase Therapeutics, Inc., Chief Scientist at Lifecode, Inc. (he founded the company in 2011), Director-Neurogenomics Division at Amnestix, Inc. (he founded the company in 2006), Professor at the University of Pittsburgh, Faculty Member at George Washington University, Faculty Member at Arizona State University, Faculty Member at The Johns Hopkins University, Faculty Member at the University of Arizona, Executive Director-Gene Partnership at The Children's Hospital Corp., Chairman-Neurogenomics Department & Professor at Translational Genomics Research Institute and Executive Director-Gene Partnership at Harvard Medical School.

Dr. Stephan received an undergraduate degree from Carnegie Mellon University and a doctorate from the University of Pittsburgh Graduate School of Public Health.

Transactions

Date Shares Transaction Value
04/26/2021 12,000   Acquisition at $5 per share. 60,000
12/01/2020 1,273,820   Gift at $0 per share. 0
12/01/2020 1,273,819   Gift at $0 per share. 0
11/30/2020 1,273,819   Gift at $0 per share. 0
11/23/2020 2,547,639   Gift at $0 per share. 0
06/09/2020 1,275   Acquisition at $7.73 per share. 9,855
05/21/2020 1,250   Acquisition at $8.09 per share. 10,112
04/30/2020 10,000   Acquisition at $6 per share. 60,000
07/12/2019 2,547,639   Award at $0 per share. 0

Officers and Executives

Dr. Dietrich A. Stephan
Chairman, President, CEO & Chief Financial Officer
Dr. William R. Mann
Chief Operating Officer
Mr. Robert Friedlander
Chief Medical Officer
Dr. Curt W. Bradshaw
Chief Scientific Officer
Dr. Sandra Porcile Rojas-Caro
Chief Medical Officer
Dr. Anthony Rossomando
Chief Technology Officer
Ms. Shannon McCarthy
Chief People Officer
Dr. Dov A. Goldstein
Independent Director
Dr. Franklyn G. Prendergast
Independent Director
Mr. Eric I. Richman
Independent Director
Mr. Gerald J. McDougall
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.